Esther Schlossberg, BA
Manager, ResearchCards
Contact Info
About
Copy Link
Titles
Manager, Research
Biography
Esther Schlossberg is a Project Coordinator for InSTRIDE, where she manages research initiatives focused on substance use disorders and infectious diseases. She brings over five years of experience in public health research and program coordination, with expertise in community health, opioid overdose prevention, and supporting justice-system–involved populations.
Esther began her career with InSTRIDE as a Postgraduate Research Associate in 2020 and has since contributed to the development, coordination, and implementation of multiple studies at the intersection of substance use, infectious diseases, and health equity. Her work has included coordinating multi-site research projects, supporting community advisory boards, and fostering collaborations with community-based organizations and health systems.
Her previous professional experience includes working for the Connecticut Department of Public Health and St. Luke’s University Health Network in Allentown, PA on statewide and community-based initiatives to address the opioid epidemic. She has contributed to public health campaigns aimed at reducing prescription drug misuse, supported the development of digital tools to respond to overdose, and played a key role in expanding access to naloxone through community training initiatives. Across these roles, Esther has focused on ensuring that interventions are community-driven, evidence-based, and responsive to the needs of those most affected.
Esther holds bachelor’s degrees in Public Health and Jewish Studies from Muhlenberg College. She is deeply committed to advancing public health practice and research that reduces health disparities, strengthens community resilience, and improves care for underserved and marginalized populations.
Departments & Organizations
Education & Training
- BA
- Muhlenberg College, Public Health (2020)
Research
Copy Link
Research at a Glance
Yale Co-Authors
Sandra Ann Springer, MD
Angela Di Paola, PhD
Brent Vander Wyk, PhD
Albert C Shaw, MD, PhD
Publications
2025
Initiating Injectable Buprenorphine in People Hospitalized With Infections
Seval N, Roth P, Frank C, Di Paola A, Litwin A, Vander Wyk B, Neirinckx V, Schlossberg E, Lawson P, Strong M, Schade M, Nunez J, Levin F, Brady K, Nunes E, Springer S. Initiating Injectable Buprenorphine in People Hospitalized With Infections. JAMA Network Open 2025, 8: e2513000. PMID: 40445619, PMCID: PMC12125644, DOI: 10.1001/jamanetworkopen.2025.13000.Peer-Reviewed Original ResearchCitationsAltmetric
2022
Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons
Springer SA, Nijhawan AE, Knight K, Kuo I, Di Paola A, Schlossberg E, Frank CA, Sanchez M, Pankow J, Proffitt RP, Lehman W, Pulitzer Z, Thompson K, Violette S, Harding KK. Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons. BMC Infectious Diseases 2022, 22: 380. PMID: 35428213, PMCID: PMC9013109, DOI: 10.1186/s12879-022-07354-x.Peer-Reviewed Original ResearchCitationsAltmetricFactors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community
Biondi BE, Vander Wyk B, Schlossberg EF, Shaw A, Springer SA. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community. Addiction Science & Clinical Practice 2022, 17: 15. PMID: 35255967, PMCID: PMC8899775, DOI: 10.1186/s13722-022-00299-1.Peer-Reviewed Original ResearchCitationsAltmetric
2021
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions
Taweh N, Schlossberg E, Frank C, Nijhawan A, Kuo I, Knight K, Springer SA. Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions. International Journal Of Drug Policy 2021, 96: 103283. PMID: 34020864, PMCID: PMC8568621, DOI: 10.1016/j.drugpo.2021.103283.Peer-Reviewed Original ResearchCitationsAltmetric
News
Copy Link
News
Get In Touch
Copy Link